Precision Business Insights has published a report on the global opioid induced constipation treatment market, estimating its value at USD 70.3 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 6.6% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/global-opioid-induced-constipation-treatment-market

Market Definition:

Opioid-induced constipation (OIC) refers to constipation caused by opioid medications, which slow down bowel movements by affecting opioid receptors in the gut. It is a common side effect of opioids used for pain management, leading to symptoms like hard stools, straining, and infrequent bowel movements.

Drivers:

1)      Rising opioid prescription rates.

2)      Increasing in drug development

The global opioid induced constipation treatment market segmentation:
1) By Drug Type: Peripherally restricted-opioid receptor antagonists, Non-selective opioid antagonists, Locally acting chloride channel activators.
2) By Formulation Type: Solids, Semi-solids, Liquids.
3) By Administration: Oral, Parenteral.
4) By Distribution Channel: Drugstore, Retail pharmacies, Hospital pharmacies.

Regional Overview:
The report also examines the current concerns and their Future Effects on the opioid induced constipation treatment market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the opioid induced constipation treatment market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like GlaxoSmithKline plc (U.K.), AstraZeneca U.K), Pfizer Inc. (U.S.), SLA Pharma AG (U.K.), AIKO Biotechnology, Inc. (U.S.), Cubist Pharmaceuticals (Merck & Co. Inc.,) (U.S.), Takeda Pharmaceutical Company Limited (Japan), Boehringer Ingelheim GmbH (Germany), Bayer AG (Germany), Valeant (Canada), Abbott Laboratories (U.S.), Purdue Pharma LP (U.S.), Shionogi Inc. (U.S.), Cosmo Pharmaceutical  N.V. (Ireland)

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747